These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29214766)

  • 1. Abrupt Increase in Rate of Imipenem Resistance in Acinetobacter baumannii Complex Strains Isolated from General Hospitals in Korea and Correlation With Carbapenem Administration During 2002-2013.
    Kim YA; Park YS; Youk T; Lee H; Lee K
    Ann Lab Med; 2018 Mar; 38(2):179-181. PubMed ID: 29214766
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of the 29-kilodalton outer membrane protein in the presence of OXA-51-like enzymes in Acinetobacter baumannii is associated with decreased imipenem susceptibility.
    Jeong HW; Cheong HJ; Kim WJ; Kim MJ; Song KJ; Song JW; Kim HS; Roh KH
    Microb Drug Resist; 2009 Sep; 15(3):151-8. PubMed ID: 19728771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and spread of integron-IS26 in imipenem-resistant Acinetobacter baumannii clinical isolates in South Korea.
    Jeoung OY; Jang SJ; Li XM; Park G; Yong DE; Kang JO; Koo SH; Kim WY; Kim EC; Park YJ; Song WK; Shin JH; Ahn JY; Uh Y; Lee KW; Lee SH; Lee WG; Lee HS; Choi TY; Cho JH; Jeong SH; Hong SG; Lee J; Kim DM; Chang CL; Shin SH; Moon DS; Park YJ
    Int J Antimicrob Agents; 2009 Dec; 34(6):612-4. PubMed ID: 19735991
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin System.
    Fernández-García L; Fernandez-Cuenca F; Blasco L; López-Rojas R; Ambroa A; Lopez M; Pascual Á; Bou G; Tomás M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
    Alcántar-Curiel MD; García-Torres LF; González-Chávez MI; Morfín-Otero R; Gayosso-Vázquez C; Jarillo-Quijada MD; Fernández-Vázquez JL; Giono-Cerezo S; Rodríguez-Noriega E; Santos-Preciado JI
    Arch Med Res; 2014 Oct; 45(7):553-60. PubMed ID: 25450581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy.
    Bertini A; Giordano A; Varesi P; Villa L; Mancini C; Carattoli A
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2268-9. PubMed ID: 16723603
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
    Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OXA-23-type imipenem resistance in Acinetobacter baumannii in Hong Kong.
    Chu YW; Cheung TK; Chu MY; Lo JY; Dijkshoorn L
    Int J Antimicrob Agents; 2009 Sep; 34(3):285-6. PubMed ID: 19394202
    [No Abstract]   [Full Text] [Related]  

  • 10. Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain.
    Guerrero-Lozano I; Fernández-Cuenca F; Galán-Sánchez F; Egea P; Rodríguez-Iglesias M; Pascual Á
    Microb Drug Resist; 2015 Apr; 21(2):215-7. PubMed ID: 25386800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary investigation of the molecular mechanisms of imipenem-resistance in clinical isolates of Acinetobacter baumannii in Xi'an].
    Tan XS; Liu Y; Han XP
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1393-6. PubMed ID: 19620063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of OXA-23 and OXA-58 Carbapenemases Coexpressed in Clinical Isolates of Acinetobacter baumannii in Tunisia.
    Mathlouthi N; Ben Lamine Y; Somai R; Bouhalila-Besbes S; Bakour S; Rolain JM; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):136-141. PubMed ID: 28691891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime-susceptible and imipenem-non-susceptible OXA-58-producing Acinetobacter baumannii from the Comoros archipelago.
    Bonnin RA; Poirel L; Benoit-Cattin T; Nordmann P
    Int J Antimicrob Agents; 2013 Mar; 41(3):297-8. PubMed ID: 23313400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and epidemiological characterization of infections due to imipenem resistant Acinetobacter baumannii at the university hospital Sahloul, Tunisia].
    Mansour W; Bouallegue O; Jeday S; Naïja W; Boujaafar N
    Ann Biol Clin (Paris); 2007; 65(6):593-9. PubMed ID: 18039603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
    Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
    Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon.
    Hammoudi D; Moubareck CA; Hakime N; Houmani M; Barakat A; Najjar Z; Suleiman M; Fayad N; Sarraf R; Sarkis DK
    Int J Infect Dis; 2015 Jul; 36():56-61. PubMed ID: 26004171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the dynamics of imipenem-resistant Acinetobacter baumannii lineages within Portugal.
    Grosso F; Quinteira S; Peixe L
    Clin Microbiol Infect; 2011 Aug; 17(8):1275-9. PubMed ID: 21375660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?
    Tamma PD; Wang R; Lewis S; Opene BNA; Simner PJ
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1378-1379. PubMed ID: 28965496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.